Enveric Biosciences, Inc.
corporate_fare Company Profile
Enveric Biosciences, Inc. (NASDAQ:ENVB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for ENVB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ENVB spans 10-Q, 8-K, 424B5, 424B3.
Recent high-impact activity:
- Enveric Q2 10-Q: $3.0M Loss, Going Concern Warning, and $8.3M Cash
- Enveric Reports Q2 Loss of $3.0M, $8.3M Cash, and $6.5M in New Financing
- New Preclinical Data Reinforces Non-Hallucinogenic Profile of Enveric's Lead Candidate EB-003
- Enveric Biosciences Expands Highly Dilutive ATM Offering by $2.4M Amidst Going Concern Warning
- Enveric Biosciences Unveils Q2 2026 Investor Presentation Highlighting Neuroplastogen Pipeline & EB-003 Progress
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ENVB, detected from its recent SEC filings · based on capital-structure filings through 2026-06-09.
ATM Offering Expanded · Significant Prior Sales
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →